Crossmark

Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study)

Crossref DOI link: https://doi.org/10.1007/s00011-021-01516-4

Published Online: 2021-10-30

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

García de Guadiana-Romualdo, Luis https://orcid.org/0000-0003-3028-3198
Rodríguez Rojas, Carlos

Morell-García, Daniel

Andaluz-Ojeda, David

Rodríguez Mulero, María Dolores

Rodríguez-Borja, Enrique

Ballesteros-Vizoso, Antonieta

Calvo, María Dolores

Albert-Botella, Lourdes

Pozo Giráldez, Adela

Llompart-Alabern, Isabel

Bolado Jiménez, Cristina

Hernández Olivo, Marta

Fernández Presa, Lucía

Ortega-Pérez, Juan

Fora Romero, María José

Campos-Rodríguez, Valerio

Ballester Férriz, Andrea

Guiu-Martí, Alexandra M.

Pinilla Arribas, Leyre

Galindo Martínez, María

Puerto-Lara, Edwin R.

López Tarazaga, Ana Belen

Ros Braquehais, María Salomé

Nogales Martín, Leonor

Juez Santamaría, Celia

Trapiello Fernández, Wysalli

Espinilla Fernández, Virginia

Havelka, Aleksandra

Albaladejo-Otón, María Dolores
License Information

Text and Data Mining valid from 2021-10-30

Version of Record valid from 2021-10-30
More Information

Article History

Received: 17 May 2021

Revised: 21 October 2021

Accepted: 23 October 2021

First Online: 30 October 2021

Declarations

:

: Aleksandra Havelka is employed by Gentian AS. Other authors state no conflict of interest.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below